Biomarker evaluation and validation are the key steps, and remain the bottleneck in biomarker development processes. Prospect Biosystems' unique technology and proprietary statistical method will provide you:

• Fractionation and enrichment of the marker into well-defined specific subcellular locations for control and experimental sample groups
• Calculation of the marker’s relative % distribution among fractions
• Statistical analysis of the marker based on its differential clustering between control and experimental sample groups
• Evaluation of the marker’s applicability to differentiate between control and experimental sample groups